Apoferritin nanocages for targeted delivery of idarubicin against breast cancer cells
Volume: 69, Issue: 3, Pages: 1061 - 1067
Published: May 9, 2021
Abstract
In recent years, nanotechnology has attracted attention for its capability to diagnose and remedy diverse tumors successfully. Protein nanocarriers as a platform of targeted drug delivery can be used to reduce toxicity and improve the effect of anticancer drugs. Idarubicin (IDR) is a chemotherapy drug that is classified as an anthracycline antitumor. In this study, IDR was encapsulated within horse spleen apoferritin (HsAFr) nanocarriers....
Paper Details
Title
Apoferritin nanocages for targeted delivery of idarubicin against breast cancer cells
Published Date
May 9, 2021
Volume
69
Issue
3
Pages
1061 - 1067
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History